These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 11519827)

  • 21. Establishing human prostate cancer cell xenografts in bone: induction of osteoblastic reaction by prostate-specific antigen-producing tumors in athymic and SCID/bg mice using LNCaP and lineage-derived metastatic sublines.
    Wu TT; Sikes RA; Cui Q; Thalmann GN; Kao C; Murphy CF; Yang H; Zhau HE; Balian G; Chung LW
    Int J Cancer; 1998 Sep; 77(6):887-94. PubMed ID: 9714059
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of host microenvironment on the microcirculation of human colon adenocarcinoma.
    Fukumura D; Yuan F; Monsky WL; Chen Y; Jain RK
    Am J Pathol; 1997 Sep; 151(3):679-88. PubMed ID: 9284816
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bombesin stimulates nuclear factor kappa B activation and expression of proangiogenic factors in prostate cancer cells.
    Levine L; Lucci JA; Pazdrak B; Cheng JZ; Guo YS; Townsend CM; Hellmich MR
    Cancer Res; 2003 Jul; 63(13):3495-502. PubMed ID: 12839933
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Wild-type p53 suppresses angiogenesis in human leiomyosarcoma and synovial sarcoma by transcriptional suppression of vascular endothelial growth factor expression.
    Zhang L; Yu D; Hu M; Xiong S; Lang A; Ellis LM; Pollock RE
    Cancer Res; 2000 Jul; 60(13):3655-61. PubMed ID: 10910082
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cyclooxygenase-2 promotes prostate cancer progression.
    Fujita H; Koshida K; Keller ET; Takahashi Y; Yoshimito T; Namiki M; Mizokami A
    Prostate; 2002 Nov; 53(3):232-40. PubMed ID: 12386924
    [TBL] [Abstract][Full Text] [Related]  

  • 26. VEGF(121), VEGF(165) overexpression enhances tumorigenicity in U251 MG but not in NG-1 glioma cells.
    Ke LD; Shi YX; Yung WK
    Cancer Res; 2002 Mar; 62(6):1854-61. PubMed ID: 11912165
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Suppression of ganglioside GD3 expression in a rat F-11 tumor cell line reduces tumor growth, angiogenesis, and vascular endothelial growth factor production.
    Zeng G; Gao L; Birklé S; Yu RK
    Cancer Res; 2000 Dec; 60(23):6670-6. PubMed ID: 11118051
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of oncogenes in tumor angiogenesis: mutant K-ras up-regulation of vascular endothelial growth factor/vascular permeability factor is necessary, but not sufficient for tumorigenicity of human colorectal carcinoma cells.
    Okada F; Rak JW; Croix BS; Lieubeau B; Kaya M; Roncari L; Shirasawa S; Sasazuki T; Kerbel RS
    Proc Natl Acad Sci U S A; 1998 Mar; 95(7):3609-14. PubMed ID: 9520413
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of growth of C6 glioma cells in vivo by expression of antisense vascular endothelial growth factor sequence.
    Saleh M; Stacker SA; Wilks AF
    Cancer Res; 1996 Jan; 56(2):393-401. PubMed ID: 8542597
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Angiogenic potential of prostate carcinoma cells overexpressing bcl-2.
    Fernandez A; Udagawa T; Schwesinger C; Beecken W; Achilles-Gerte E; McDonnell T; D'Amato R
    J Natl Cancer Inst; 2001 Feb; 93(3):208-13. PubMed ID: 11158189
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Angiogenically active vascular endothelial growth factor is over-expressed in malignant human and rat prostate carcinoma cells.
    Chen HJ; Treweeke AT; Ke YQ; West DC; Toh CH
    Br J Cancer; 2000 May; 82(10):1694-701. PubMed ID: 10817506
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modulation of in vivo growth of thyroid tumor-derived cell lines by sense and antisense vascular endothelial growth factor gene.
    Belletti B; Ferraro P; Arra C; Baldassarre G; Bruni P; Staibano S; De Rosa G; Salvatore G; Fusco A; Persico MG; Viglietto G
    Oncogene; 1999 Aug; 18(34):4860-9. PubMed ID: 10490819
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vascular endothelial growth factor (VEGF) modulation by targeting hypoxia-inducible factor-1alpha--> hypoxia response element--> VEGF cascade differentially regulates vascular response and growth rate in tumors.
    Tsuzuki Y; Fukumura D; Oosthuyse B; Koike C; Carmeliet P; Jain RK
    Cancer Res; 2000 Nov; 60(22):6248-52. PubMed ID: 11103778
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of the tumor vasculature and metastatic behavior of xenografts of human melanoma cell lines transfected with vascular permeability factor.
    Pötgens AJ; van Altena MC; Lubsen NH; Ruiter DJ; de Waal RM
    Am J Pathol; 1996 Apr; 148(4):1203-17. PubMed ID: 8644861
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gene therapy for pancreatic cancer using an adenovirus vector encoding soluble flt-1 vascular endothelial growth factor receptor.
    Hoshida T; Sunamura M; Duda DG; Egawa S; Miyazaki S; Shineha R; Hamada H; Ohtani H; Satomi S; Matsuno S
    Pancreas; 2002 Aug; 25(2):111-21. PubMed ID: 12142732
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vascular endothelial growth factor mediated angiogenic potential of pancreatic ductal carcinomas enhanced by hypoxia: an in vitro and in vivo study.
    Sipos B; Weber D; Ungefroren H; Kalthoff H; Zühlsdorff A; Luther C; Török V; Klöppel G
    Int J Cancer; 2002 Dec; 102(6):592-600. PubMed ID: 12448000
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of vascular endothelial growth factor induces an invasive phenotype in human squamous cell carcinomas.
    Detmar M; Velasco P; Richard L; Claffey KP; Streit M; Riccardi L; Skobe M; Brown LF
    Am J Pathol; 2000 Jan; 156(1):159-67. PubMed ID: 10623663
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Inhibition of K562 cell growth and tumor angiogenesis in nude mice by antisense VEGF(121) cDNA transfection].
    Ruan G; Liu Y; Chen S; Qin Y; Li J; Fu J; Yu H; Chang Y
    Zhonghua Xue Ye Xue Za Zhi; 2002 Apr; 23(4):179-82. PubMed ID: 12133452
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-vascular endothelial growth factor receptor 2 antibody reduces tumorigenicity and metastasis in orthotopic prostate cancer xenografts via induction of endothelial cell apoptosis and reduction of endothelial cell matrix metalloproteinase type 9 production.
    Sweeney P; Karashima T; Kim SJ; Kedar D; Mian B; Huang S; Baker C; Fan Z; Hicklin DJ; Pettaway CA; Dinney CP
    Clin Cancer Res; 2002 Aug; 8(8):2714-24. PubMed ID: 12171905
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vascular endothelial growth factor-mediated autocrine stimulation of prostate tumor cells coincides with progression to a malignant phenotype.
    Soker S; Kaefer M; Johnson M; Klagsbrun M; Atala A; Freeman MR
    Am J Pathol; 2001 Aug; 159(2):651-9. PubMed ID: 11485923
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.